1 |
Siddiqi N, Harrison JK, Clegg A, Teale EA, Young J, Taylor J, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev 2016;3:CD005563.
|
2 |
Guo Y, Sun L, Li L, Jia P, Zhang J, Jiang H, et al. Impact of multicomponent, nonpharmacologic interventions on perioperative cortisol and melatonin levels and postoperative delirium in elderly oral cancer patients. Arch Gerontol Geriatr 2016;62:112-7.
DOI
|
3 |
Zaal IJ, Slooter AJ. Delirium in critically ill patients: epidemiology, pathophysiology, diagnosis and management. Drugs 2012;72:1457-71.
DOI
|
4 |
Griffin ÉW, Skelly DT, Murray CL, Cunningham C. Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction. J Neurosci 2013;33:15248-58.
DOI
|
5 |
Matsuoka H, Yoshiuchi K, Koyama A, Otsuka M, Nakagawa K. Chemotherapeutic drugs that penetrate the blood-brain barrier affect the development of hyperactive delirium in cancer patients. Palliat Support Care 2015;13:859-64.
DOI
|
6 |
Gaudreau JD, Gagnon P. Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus. Med Hypotheses 2005;64:471-5.
DOI
|
7 |
Caraceni A. Drug-associated delirium in cancer patients. EJC Suppl 2013;11:233-40.
DOI
|
8 |
Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002;43:175-82.
DOI
|
9 |
Kishi Y, Kato M, Okuyama T, Thurber S. Treatment of delirium with risperidone in cancer patients. Psychiatry Clin Neurosci 2012;66:411-7.
DOI
|
10 |
Prommer E. Role of haloperidol in palliative medicine: an update. Am J Hosp Palliat Care 2012;29:295-301.
DOI
|
11 |
Tanimukai H, Tsujimoto H, Matsuda Y, Tokoro A, Kanemura S, Watanabe M, et al. Novel Therapeutic Strategies for Delirium in Patients With Cancer: A Preliminary Study. Am J Hosp Palliat Care 2016;33:456-62.
DOI
|
12 |
Hui D, Bush SH, Gallo LE, Palmer JL, Yennurajalingam S, Bruera E. Neuroleptic dose in the management of delirium in patients with advanced cancer. J Pain Symptom Manage 2010;39:186-96.
DOI
|
13 |
Hilliard N, Brown S, Mitchinson S. A case report of dexmedetomidine used to treat intractable pain and delirium in a tertiary palliative care unit. Palliat Med 2015;29:278-81.
DOI
|
14 |
Daud ML. Drug management of terminal symptoms in advanced cancer patients. Curr Opin Support Palliat Care 2007;1:202-6.
DOI
|
15 |
Shin SH, Hui D, Chisholm G, Kang JH, Allo J, Williams J, et al. Frequency and Outcome of Neuroleptic Rotation in the Management of Delirium in Patients with Advanced Cancer. Cancer Res Treat 2015;47:399-405.
|
16 |
Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol 2012;30:1206-14.
DOI
|
17 |
Hjermstad M, Loge JH, Kaasa S. Methods for assessment of cognitive failure and delirium in palliative care patients: implications for practice and research. Palliat Med 2004;18:494-506.
DOI
|
18 |
Zimmerman KM, Salow M, Skarf LM, Kostas T, Paquin A, Simone MJ, et al. Increasing anticholinergic burden and delirium in palliative care inpatients. Palliat Med 2014;28:335-41.
DOI
|
19 |
Tahir TA. A review for usefulness of atypical antipsychotics and cholinesterase inhibitors in delirium. Pharmacopsychiatry 2012;45:163; author reply 164.
DOI
|
20 |
Kang JH, Shin SH, Bruera E. Comprehensive approaches to managing delirium in patients with advanced cancer. Cancer Treat Rev 2013;39:105-12.
DOI
|
21 |
Sfera A, Cummings M, Osorio C. Non-Neuronal Acetylcholine: The Missing Link Between Sepsis, Cancer, and Delirium? Front Med (Lausanne) 2015;2:56.
|
22 |
Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med 2004;18:184-94.
DOI
|
23 |
Grassi L, Caraceni A, Mitchell AJ, Nanni MG, Berardi MA, Caruso R, et al. Management of delirium in palliative care: a review. Curr Psychiatry Rep 2015;17:550.
|
24 |
Minagawa H, Uchitomi Y, Yamawaki S, Ishitani K. Psychiatric morbidity in terminally ill cancer patients. A prospective study. Cancer 1996;78:1131-7.
DOI
|
25 |
Combs D, Rice SA, Kopp LM. Incidence of delirium in children with cancer. Pediatr Blood Cancer 2014;61:2094-5.
DOI
|
26 |
Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 2001;22:997-1006.
DOI
|
27 |
Uchida M, Okuyama T, Ito Y, Nakaguchi T, Miyazaki M, Sakamoto M, et al. Prevalence, course and factors associated with delirium in elderly patients with advanced cancer: a longitudinal observational study. Jpn J Clin Oncol 2015;45:934-40.
DOI
|
28 |
European Delirium Association; American Delirium Society. The DSM-5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer. BMC Med 2014;12:141.
DOI
|
29 |
Rainsford S, Rosenberg JP, Bullen T. Delirium in advanced cancer: screening for the incidence on admission to an inpatient hospice unit. J Palliat Med 2014;17:1045-8.
DOI
|
30 |
de la Cruz M, Noguera A, San Miguel-Arregui MT, Williams J, Chisholm G, Bruera E. Delirium, agitation, and symptom distress within the final seven days of life among cancer patients receiving hospice care. Palliat Support Care 2015;13:211-6.
DOI
|
31 |
Hosie A, Lobb E, Agar M, Davidson PM, Chye R, Phillips J. Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: a focus group study. J Clin Nurs 2015;24:3276-85.
DOI
|
32 |
Kim KN, Kim CH, Kim KI, Yoo HJ, Park SY, Park YH. Development and validation of the Korean Nursing Delirium Scale. J Korean Acad Nurs 2012;42:414-23.
DOI
|
33 |
Lee Y, Ryu J, Lee J, Kim HJ, Shin IH, Kim JL, et al. Korean version of the delirium rating scale-revised-98: reliability and validity. Psychiatry Investig 2011;8:30-8.
DOI
|
34 |
Leonard MM, Nekolaichuk C, Meagher DJ, Barnes C, Gaudreau JD, Watanabe S, et al. Practical assessment of delirium in palliative care. J Pain Symptom Manage 2014;48:176-90.
DOI
|
35 |
Korc-Grodzicki B, Sun SW, Zhou Q, Iasonos A, Lu B, Root JC, et al. Geriatric assessment as a predictor of delirium and other outcomes in elderly patients with cancer. Ann Surg 2015;261:1085-90.
DOI
|
36 |
Hey J, Hosker C, Ward J, Kite S, Speechley H. Delirium in palliative care: Detection, documentation and management in three settings. Palliat Support Care 2015;13:1541-5.
DOI
|
37 |
Maldonado JR. Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin 2008;24:789-856.
DOI
|
38 |
Siddiqi N, Stockdale R, Britton AM, Holmes J. Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev 2007;18:CD005563.
|